STRIATAL N-METHYL-D-ASPARTATE RECEPTORS IN HALOPERIDOL-INDUCED CATALEPSY

被引:0
|
作者
YOSHIDA, Y
ONO, T
KIZU, A
FUKUSHIMA, R
MIYAGISHI, T
机构
关键词
CATALEPSY; HALOPERIDOL; NMDA RECEPTORS; DOPAMINE; GLUTAMATE; CAUDATE-PUTAMEN; (RAT);
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Bilateral ablation of the frontal cortex of rats markedly reduced the catalepsy induced by haloperidol (1 mg/kg i.p.). Similarly, the selective antagonist of N-methyl-D-aspartate (NMDA) receptors, D(-)-2-amino-5-phosphonopentanoic acid (10-mu-g/side), injected bilaterally into the rostral part of the caudate-putamen (CP) reduced haloperidol-induced catalepsy whereas its injection into the intermediate part of the CP was ineffective. The quisqualate receptor antagonist, L-glutamic acid diethyl ester (100-mu-g/side), did not affect haloperidol-induced catalepsy when injected into the rostral part of the CP. On the other hand, NMDA (1-mu-g/side) injected bilaterally into the rostral part of the CP was able to restore haloperidol-induced catalepsy in frontally decorticated rats without any notable cataleptic effect of its own. These findings suggest that a certain degree of tonic stimulatory effect of corticostriatal glutamatergic pathways on NMDA receptors within the rostral part of the CP is a prerequisite for the expression of the cataleptogenic action of haloperidol.
引用
收藏
页码:173 / 180
页数:8
相关论文
共 50 条
  • [1] Role of adenosine and N-methyl-D-aspartate receptors in mediating haloperidol-induced gene expression and catalepsy
    Chartoff, EH
    Ward, RP
    Dorsa, DM
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 291 (02): : 531 - 537
  • [2] DIFFERENTIAL-EFFECTS OF MORPHINAN DRUGS ON HALOPERIDOL-INDUCED CATALEPSY IN RATS - A COMPARATIVE-STUDY WITH AN N-METHYL-D-ASPARTATE ANTAGONIST
    DECAROLIS, AS
    POPOLI, P
    PEZZOLA, A
    SAGRATELLA, S
    [J]. ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1991, 310 : 132 - 141
  • [3] ROLE OF N-METHYL-D-ASPARTATE (NMDA) RECEPTORS IN EXPERIMENTAL CATALEPSY IN RATS
    MEHTA, AK
    TICKU, MK
    [J]. LIFE SCIENCES, 1990, 46 (01) : 37 - 42
  • [4] NICOTINE POTENTIATION OF HALOPERIDOL-INDUCED CATALEPSY - STRIATAL MECHANISMS
    SANBERG, PR
    EMERICH, DF
    ELETRI, M
    SHIPLEY, MT
    ZANOL, MD
    CAHILL, DW
    NORMAN, AB
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1993, 46 (02) : 303 - 307
  • [5] Diurnal variations of striatal D2 dopaminergic receptors and its relation with haloperidol-induced catalepsy
    Torner, C
    Sánchez-Hurtado, L
    Aguilar-Roblero, R
    [J]. BIOLOGICAL RHYTHM RESEARCH, 1998, 29 (05) : 538 - 545
  • [6] Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol
    Ilyin, VI
    Whittemore, ER
    Guastella, J
    Weber, E
    Woodward, RM
    [J]. MOLECULAR PHARMACOLOGY, 1996, 50 (06) : 1541 - 1550
  • [7] N-methyl-D-aspartate receptors in the retina
    Shen, Yin
    Liu, Xiao-Ling
    Yang, Xiong-Li
    [J]. MOLECULAR NEUROBIOLOGY, 2006, 34 (03) : 163 - 179
  • [8] N-Methyl-d-aspartate receptors in the retina
    Yin Shen
    Xiao-Ling Liu
    Xiong-Li Yang
    [J]. Molecular Neurobiology, 2006, 34 : 163 - 179
  • [9] EXCITOTOXICITY AND N-METHYL-D-ASPARTATE RECEPTORS
    OLNEY, JW
    [J]. DRUG DEVELOPMENT RESEARCH, 1989, 17 (04) : 299 - 319
  • [10] Inhibition of N-methyl-D-aspartate receptors by haloperidol: Developmental and pharmacological characterization in native and recombinant receptors
    Lynch, DR
    Gallagher, MJ
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1996, 279 (01): : 154 - 161